Vor Biopharma Inc [VOR] stock is trading at $0.87, up 4.43%. An important factor to consider is whether the stock is rising or falling in short-term value. The VOR shares have gain 10.00% over the last week, with a monthly amount glided 3.48%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Vor Biopharma Inc [NASDAQ: VOR] stock has seen the most recent analyst activity on July 26, 2022, when Wedbush initiated its Outperform rating and assigned the stock a price target of $18. Previously, Goldman started tracking the stock with Neutral rating on April 27, 2022, and set its price target to $6. On December 17, 2021, H.C. Wainwright initiated with a Buy rating and assigned a price target of $26 on the stock. Robert W. Baird started tracking the stock assigning a Outperform rating and suggested a price target of $38 on December 03, 2021. Oppenheimer initiated its recommendation with a Outperform and recommended $30 as its price target on December 02, 2021. JMP Securities started tracking with a Mkt Outperform rating for this stock on October 19, 2021, and assigned it a price target of $40. In a note dated March 25, 2021, B. Riley Securities initiated an Buy rating and provided a target price of $60 on this stock.
Vor Biopharma Inc [VOR] stock has fluctuated between $0.63 and $3.14 over the past year. Currently, Wall Street analysts expect the stock to reach $6 within the next 12 months. Vor Biopharma Inc [NASDAQ: VOR] shares were valued at $0.87 at the most recent close of the market. An investor can expect a potential return of 589.66% based on the average VOR price forecast.
Analyzing the VOR fundamentals
Gross Profit Margin for this corporation currently stands at 0.78% with Operating Profit Margin at -9.65%, Pretax Profit Margin comes in at -9.2%, and Net Profit Margin reading is -9.2%. To continue investigating profitability, this company’s Return on Assets is posted at -0.97, Equity is -1.01 and Total Capital is -1.16.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.8344 points at the first support level, and at 0.7997 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.9013, and for the 2nd resistance point, it is at 0.9335.
Ratios To Look Out For
For context, Vor Biopharma Inc’s Current Ratio is 4.69. On the other hand, the Quick Ratio is 4.69, and the Cash Ratio is 3.68.
Transactions by insiders
Recent insider trading involved Attar Eyal C., CHIEF MEDICAL OFFICER, that happened on Jun 03 ’24 when 14645.0 shares were sold.
